Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors - PubMed (original) (raw)
Case Reports
. 1999 Jun 15;59(12):2776-80.
Affiliations
- PMID: 10383129
Case Reports
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors
C A Griffin et al. Cancer Res. 1999.
Abstract
Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor. The reactive versus neoplastic pathogenesis of this tumor is unresolved. We found clonal chromosome aberrations involving 2p23 upon metaphase analysis of two IMTs. Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochemistry revealed ALK expression in all three cases. 2p22-24 involvement has been reported previously in four additional cases of IMT. We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.
Similar articles
- Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, Daines C, Coffin CM. Cessna MH, et al. Mod Pathol. 2002 Sep;15(9):931-8. doi: 10.1097/01.MP.0000026615.04130.1F. Mod Pathol. 2002. PMID: 12218210 - ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.
Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. Coffin CM, et al. Mod Pathol. 2001 Jun;14(6):569-76. doi: 10.1038/modpathol.3880352. Mod Pathol. 2001. PMID: 11406658 - [Inflammatory myofibroblastic tumors].
Sirvent N, Coindre JM, Pedeutour F. Sirvent N, et al. Ann Pathol. 2002 Dec;22(6):453-60. Ann Pathol. 2002. PMID: 12594387 Review. French. - The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC, McDermott R. Kelleher FC, et al. Eur J Cancer. 2010 Sep;46(13):2357-68. doi: 10.1016/j.ejca.2010.04.006. Epub 2010 May 5. Eur J Cancer. 2010. PMID: 20451371 Review.
Cited by
- Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.
Monaghan SA, Dai L, Mapara MY, Normolle DP, Gollin SM, Lentzsch S. Monaghan SA, et al. Leuk Lymphoma. 2013 Sep;54(9):1965-74. doi: 10.3109/10428194.2012.755177. Epub 2013 Jan 28. Leuk Lymphoma. 2013. PMID: 23216269 Free PMC article. - Granulation tissue-like spindle cell (sarcomatoid) carcinoma of the head and neck: a deceptively bland-looking underdiagnosed malignancy.
Franchi A, Agaimy A. Franchi A, et al. Virchows Arch. 2024 May;484(5):799-806. doi: 10.1007/s00428-024-03770-3. Epub 2024 Feb 26. Virchows Arch. 2024. PMID: 38403668 Free PMC article. - ALK-immunoreactive neoplasms.
Minoo P, Wang HY. Minoo P, et al. Int J Clin Exp Pathol. 2012;5(5):397-410. Epub 2012 May 23. Int J Clin Exp Pathol. 2012. PMID: 22808292 Free PMC article. Review. - Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
Rodig SJ, Mino-Kenudson M, Dacic S, Yeap BY, Shaw A, Barletta JA, Stubbs H, Law K, Lindeman N, Mark E, Janne PA, Lynch T, Johnson BE, Iafrate AJ, Chirieac LR. Rodig SJ, et al. Clin Cancer Res. 2009 Aug 15;15(16):5216-23. doi: 10.1158/1078-0432.CCR-09-0802. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671850 Free PMC article. - Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
Chang JC, Zhang L, Drilon AE, Chi P, Alaggio R, Borsu L, Benayed R, Travis WD, Ladanyi M, Antonescu CR. Chang JC, et al. J Thorac Oncol. 2019 May;14(5):825-834. doi: 10.1016/j.jtho.2018.12.003. Epub 2018 Dec 11. J Thorac Oncol. 2019. PMID: 30550870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources